Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03541369 · TERMINATED
Trial details
- NCT number
- NCT03541369
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2023-02-21
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.